Background: Multiple pharmacologic treatments have been studied for patients with acute
respiratory distress syndrome (ARDS) and acute lung injury (ALI). Our objective was to …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Background Our objective was to systematically review the effect of pharmacological
therapies on mortality in patients with acute respiratory distress syndrome (ARDS), focusing …

The acute respiratory distress syndrome (ARDS) was first described by Ashbaugh and
colleagues in 1967. However, despite considerable efforts, early progress in treatment was …

Pharmacologic therapies for adults with acute lung injury and acute respiratory distress
syndrome - Adhikari, NKJ - 2004 | Cochrane Library Alert Some users are currently having …

Background Acute respiratory distress syndrome (ARDS) is a life‐threatening condition
caused by direct or indirect injury to the lungs. Despite improvements in clinical …

Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

Pharmacological treatments for acute respiratory distress sy... : Current Opinion in Critical Care
Pharmacological treatments for acute respiratory distress syndrome : Current Opinion in …

Without tighter definitions of the condition under treatment, more specific targets for
interventions to act upon, stratification that recognizes key interactive elements, and …

Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …